170 related articles for article (PubMed ID: 12660929)
1. Immunogenicity and immunological priming of the serogroup a portion of a bivalent meningococcal A/C conjugate vaccine in 2-year-old children.
Joseph H; Ryall R; Bybel M; Papa T; MacLennan J; Buttery J; Borrow R
J Infect Dis; 2003 Apr; 187(7):1142-6. PubMed ID: 12660929
[TBL] [Abstract][Full Text] [Related]
2. Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults.
Southern J; Deane S; Ashton L; Borrow R; Goldblatt D; Andrews N; Balmer P; Morris R; Kroll JS; Miller E
Clin Diagn Lab Immunol; 2004 Nov; 11(6):1100-4. PubMed ID: 15539513
[TBL] [Abstract][Full Text] [Related]
3. Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children.
Borrow R; Goldblatt D; Andrews N; Richmond P; Southern J; Miller E
J Infect Dis; 2001 Aug; 184(3):377-80. PubMed ID: 11443568
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
Perrett KP; Snape MD; Ford KJ; John TM; Yu LM; Langley JM; McNeil S; Dull PM; Ceddia F; Anemona A; Halperin SA; Dobson S; Pollard AJ
Pediatr Infect Dis J; 2009 Mar; 28(3):186-93. PubMed ID: 19209097
[TBL] [Abstract][Full Text] [Related]
5. Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidis serogroup C in young adults.
Goldblatt D; Borrow R; Miller E
J Infect Dis; 2002 Feb; 185(3):397-400. PubMed ID: 11807724
[TBL] [Abstract][Full Text] [Related]
6. Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine.
Richmond P; Kaczmarski E; Borrow R; Findlow J; Clark S; McCann R; Hill J; Barker M; Miller E
J Infect Dis; 2000 Feb; 181(2):761-4. PubMed ID: 10669372
[TBL] [Abstract][Full Text] [Related]
7. Avidity of serogroup A meningococcal IgG antibodies after immunization with different doses of a tetravalent A/C/Y/W135 polysaccharide vaccine.
Bårnes GK; Naess LM; Rosenqvist E; Guerin PJ; Caugant DA;
Scand J Immunol; 2011 Jul; 74(1):87-94. PubMed ID: 21332570
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
9. Immune memory in children previously vaccinated with an experimental quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine.
Pichichero M; Papa T; Blatter M; Mitchell D; Kratz R; Sneed J; Bassily E; Casey J; Gilmet G
Pediatr Infect Dis J; 2006 Nov; 25(11):995-1000. PubMed ID: 17072120
[TBL] [Abstract][Full Text] [Related]
10. Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.
Tunheim G; Arnemo M; Næss LM; Fjeldheim ÅK; Nome L; Bolstad K; Aase A; Mandiarote A; González H; González D; García L; Cardoso D; Norheim G; Rosenqvist E
Vaccine; 2013 Dec; 31(51):6097-106. PubMed ID: 24120679
[TBL] [Abstract][Full Text] [Related]
11. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
[TBL] [Abstract][Full Text] [Related]
12. Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine.
El Bashir H; Heath PT; Papa T; Ruggeberg JU; Johnson N; Sinha R; Balfour G; Booy R
Vaccine; 2006 Mar; 24(14):2544-9. PubMed ID: 16417952
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15-25 years.
Ostergaard L; Lebacq E; Poolman J; Maechler G; Boutriau D
Vaccine; 2009 Jan; 27(1):161-8. PubMed ID: 18834910
[TBL] [Abstract][Full Text] [Related]
14. Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory.
Richmond P; Borrow R; Miller E; Clark S; Sadler F; Fox A; Begg N; Morris R; Cartwright K
J Infect Dis; 1999 Jun; 179(6):1569-72. PubMed ID: 10228085
[TBL] [Abstract][Full Text] [Related]
15. Safety and preliminary immunogenicity of MenC/P64k, a meningococcal serogroup C conjugate vaccine with a new recombinant carrier.
Pérez AE; Dickinson FO; Banderas F; Serrano T; Llanes R; Guzmán D; Díaz P; Alvarez A; Guirola M; Caballero E; Canaan-Haden L; Guillén G
FEMS Immunol Med Microbiol; 2006 Apr; 46(3):386-92. PubMed ID: 16553812
[TBL] [Abstract][Full Text] [Related]
16. Investigation of serum bactericidal activity in childhood and adolescence 3-6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine.
Sakou II; Tzanakaki G; Tsolia MN; Sioumala M; Barbouni A; Kyprianou M; Papaevangelou V; Tsitsika A; Blackwell CC; Kafetzis D; Kremastinou J
Vaccine; 2009 Jul; 27(33):4408-11. PubMed ID: 19500554
[TBL] [Abstract][Full Text] [Related]
17. Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents.
Jackson LA; Baxter R; Reisinger K; Karsten A; Shah J; Bedell L; Dull PM;
Clin Infect Dis; 2009 Jul; 49(1):e1-10. PubMed ID: 19476428
[TBL] [Abstract][Full Text] [Related]
18. Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy.
MacLennan J; Obaro S; Deeks J; Lake D; Elie C; Carlone G; Moxon ER; Greenwood B
J Infect Dis; 2001 Jan; 183(1):97-104. PubMed ID: 11087205
[TBL] [Abstract][Full Text] [Related]
19. Immunologic memory with no detectable bactericidal antibody response to a first dose of meningococcal serogroup C conjugate vaccine at four years.
McVernon J; MacLennan J; Pollard AJ; Oster P; Wakefield MJ; Danzig L; Moxon ER
Pediatr Infect Dis J; 2003 Jul; 22(7):659-61. PubMed ID: 12886896
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine in 2-year old children.
Granoff DM; Morgan A; Welsch JA
Vaccine; 2005 Jul; 23(34):4307-14. PubMed ID: 15921829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
